플루옥시메스테론

플루옥시메스테론
플루옥시메스테론 구조식 이미지
카스 번호:
76-43-7
한글명:
플루옥시메스테론
동의어(한글):
플루옥시메스테론
상품명:
Fluoxymesterone
동의어(영문):
Halotestin;Halo;ora-testryl;Fluoxymestrone;Fluoxymesteron;FluoxyMesterone(Halotestin);Halotestin(Fluoxymesterone);9α-Fluoro-11β-hydroxy-17-methyltestosterone;FXM;u6040
CBNumber:
CB9258118
분자식:
C20H29FO3
포뮬러 무게:
336.44
MOL 파일:
76-43-7.mol

플루옥시메스테론 속성

녹는점
240 °C
알파
104 º (c=1,EtOH)
끓는 점
474.2±45.0 °C(Predicted)
밀도
1.0455 (estimate)
저장 조건
-20°C
용해도
H2O: ≤0.5 mg/mL
물리적 상태
고체(감광성)
산도 계수 (pKa)
13.40±0.70(Predicted)
색상
하얀색
수용성
무시할 만한
Merck
13,4212
InChI
InChI=1/C20H29FO3/c1-17-8-6-13(22)10-12(17)4-5-15-14-7-9-19(3,24)18(14,2)11-16(23)20(15,17)21/h10,14-16,23-24H,4-9,11H2,1-3H3/t14-,15-,16-,17-,18-,19-,20-/s3
InChIKey
YLRFCQOZQXIBAB-MGWAJYFFNA-N
SMILES
[C@]12(F)[C@@H](O)C[C@]3(C)[C@](CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)(O)C |&1:0,2,5,7,10,12,22,r|
CAS 데이터베이스
76-43-7(CAS DataBase Reference)
NIST
4-Androsten-3-one, 9alpha-fluoro-11beta,17beta-dihydroxy-17alpha-methyl-,(76-43-7)
EPA
Fluoxymesterone (76-43-7)
안전
  • 위험 및 안전 성명
  • 위험 및 사전주의 사항 (GHS)
위험품 표기 Xn,T,F
위험 카페고리 넘버 63-38-19-11-61-60
안전지침서 22-36-24/25-45-53
WGK 독일 3
RTECS 번호 BV8390000
HS 번호 29372900
유해 물질 데이터 76-43-7(Hazardous Substances Data)
독성 LD50 intraperitoneal in mouse: 2350mg/kg
그림문자(GHS): GHS hazard pictograms
신호 어: Warning
유해·위험 문구:
암호 유해·위험 문구 위험 등급 범주 신호 어 그림 문자 P- 코드
H361 태아 또는 생식능력에 손상을 일으킬 것으로 의심됨 생식독성 물질 구분 2 경고 P201, P202, P281, P308+P313, P405,P501
예방조치문구:
P201 사용 전 취급 설명서를 확보하시오.
P202 모든 안전 조치 문구를 읽고 이해하기 전에는 취급하지 마시오.
P280 보호장갑/보호의/보안경/안면보호구를 착용하시오.
P308+P313 노출 또는 접촉이 우려되면 의학적인 조치· 조언를 구하시오.
P405 밀봉하여 저장하시오.
P501 ...에 내용물 / 용기를 폐기 하시오.

플루옥시메스테론 MSDS


9a-Fluoro-11b,17b-dihydroxy-17a-methyl-4-androsten-3-one

플루옥시메스테론 C화학적 특성, 용도, 생산

개요

Fluoxymesterone(Halotestin) is a steroid with an androgenic property that is used in primary hypogonadism and testicular failure due to cryptorchidism, vanishing testes syndrome, or orchidectomy; and in hypogonadotrophic hypogonadism and luteinizing hormone-releasing hormone (LHRH) deficiency or pituitary hypothalamic injury from tumors, trauma, or radiation. It mimics the actions of testosterone, which is responsible for normal growth and development of the male sex organs and for the maintenance of secondary sex characteristics. In female postmenopausal patients, fluoxymesterone may be indicated in the palliation of recurrent mammary cancer.

화학적 성질

white to light yellow crystal powder

용도

Fluoxymesterone is an anabolic steroid with androgenic activity. It is used in the treatment of male hypogonadism. It showed antitumor effects on pregnancy-dependent mammary tumors TPDMT-4.

Indications

Fluoxymesterone promotes growth and development of male reproductive organs, maintains secondary sex characteristics, increases protein anabolism, and decreases protein catabolism. It is used to treat symptoms of low testosterone in adult men who have hypogonadism (a condition in which the body does not produce enough natural testosterone). It is also used for palliation of androgen-responsive recurrent mammary cancer in women who are more than 1 year but less than 5 years postmenopausal (women).

정의

ChEBI: Fluoxymesterone is an anabolic androgenic steroid, a 17beta-hydroxy steroid, an 11beta-hydroxy steroid, a fluorinated steroid and a 3-oxo-Delta(4) steroid. It has a role as an antineoplastic agent and an anabolic agent.

일반 설명

Fluoxymesterone, 9α-fluoro-11β,17β-dihydroxy-17-methylandrost-4-en-3-one, is ahighly potent, orally active androgen, about 5 to 10 timesmore potent than testosterone. It can be used for all theindications discussed previously, but its great androgenicactivity has made it useful primarily for treatment of theandrogen-deficient male.

Pharmacokinetics

By substituting a 9α-fluoro group onto an analog of 17α-methyltestosterone, fluoxymesterone has 20 times the anabolic and 10 times the androgenic activity of 17α-methyltestosterone. It has a mean half-life of 9 hours, and less than 5% of the drug is excreted unchanged. An adverse effect of fluoxymesterone is sodium and water retention that could lead to edema.

Safety Profile

Fluoxymesterone is contraindicated in male subjects with known or suspected carcinoma of the prostate gland. Prolonged use of high-dosage 17-alpha-alkyl androgens is known to have caused hypercalcemia, hepatic adenoma, hepatocellular carcinoma, and hepatitis. Fluoxymesterone, which accelerates bone maturation without producing linear growth, should be used cautiously in males with delayed puberty. Edema and CHF may occur in patients with preexisting cardiovascular problems. Androgens cause virilization in female subjects.

플루옥시메스테론 준비 용품 및 원자재

원자재

준비 용품


플루옥시메스테론 공급 업체

글로벌( 205)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Zhengzhou Hanke Import and export Trade Co. LTD
+8613838064731
sales1@zzybchem.com China 66 58
Hebei Anda Technology Co., LTD
+86-19831998802
106@hebeianda.cn China 293 58
Hubei Lange Biotechnology Co., Ltd.
+8617762501948
sales2@langebiotech.com China 154 58
Hebei Nafu Technology Co. , Ltd.
+8615075022224
17745771666@hebeinafu.com China 325 58
Doublewin Biological Technology Co., Ltd
+86-19971437628
doublewin-bella@nandrolonesteroid.com China 97 58
Wuhan Quanjinci New Material Co.,Ltd.
+8615271838296
kyra@quanjinci.com China 1532 58
hebei hongtan Biotechnology Co., Ltd
+86-86-1913198-3935 +8617331935328
sales03@chemcn.cn China 951 58
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12453 58
Shandong Huisheng Import & Export Co., Ltd.
+86-13176845580 +86-13176845580
da@zhongda-biotech.com China 248 58
Anhui Zhongda Biotechnology Co., Ltd
+8619956560829
justine@zhongda-biotech.com China 300 58

플루옥시메스테론 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved